Article,

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

, , , , , , , , , , , , , , , , , , , , , , , , , and .
The Lancet Oncology, 9 (2): 105–116 (2008)

Meta data

Tags

Users

  • @drtester

Comments and Reviews